Georg Daeschlein

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

A. Kerstan, M. Jünger, G. Daeschlein, 2021, JID innovations.